Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000015

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Feb 14, 2017
Accepted (ET)
Mar 2, 2017 · 8:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 14, 2017P500$0.0119A19,758,849D
Common StockFeb 14, 2017P500$0.013A19,759,349D
Common StockFeb 14, 2017P500$0.013A19,759,849D
Common StockFeb 14, 2017P1,000$0.0134A19,760,849D
Common StockFeb 14, 2017P500$0.013A19,761,349D
Common StockFeb 14, 2017P500$0.013A19,761,849D
Common StockFeb 15, 2017P500$0.0107A19,762,349D
Common StockFeb 15, 2017P500$0.0108A19,762,849D
Common StockFeb 15, 2017P1,000$0.011A19,763,849D
Common StockFeb 15, 2017P1,000$0.011A19,764,849D
Common StockFeb 15, 2017P1,000$0.0118A19,765,849D
Common StockFeb 15, 2017P1,000$0.0118A19,766,849D
Common StockFeb 15, 2017P500$0.0118A19,767,349D
Common StockFeb 15, 2017P200$0.0113A19,767,549D
Common StockFeb 15, 2017P1,000$0.0114A19,768,549D
Common StockFeb 15, 2017P1,000$0.0109A19,769,549D
Common StockFeb 16, 2017P1,000$0.0135A19,770,549D
Common StockFeb 17, 2017P100$0.0177A19,770,649D
Common StockFeb 21, 2017P1,000$0.0178A19,771,649D
cFeb 22, 2017P1,000$0.016A19,772,649D

Table II — derivative securities

No Table II lines on this filing.